February 24, 2012American Journal of Hematology

Reversal of antithrombotic agents

View Full Paper

Ask AI

Bookmark

Population

Patients receiving anticoagulant therapy who require reversal due to bleeding or other clinical indications.

Design

Review

Authors

KBKenneth A. BauerBoston University

Discussion

Member takes

Implication

Offers a synthesis of reversal strategies for oral anticoagulants; leaves open validation of emerging agents in prospective studies.

Structured PICO

Population

Patients receiving anticoagulant therapy (including traditional parenteral agents and new oral anticoagulants such as dabigatran etexilate, rivaroxaban, and apixaban) who require reversal due to bleeding or other clinical indications.

Intervention

Reversal agents and management strategies for bleeding events.

This review summarizes available and future options for reversing the effects of traditional and new oral anticoagulants to manage bleeding complications.

Cite This Study

Kenneth A. Bauer (2012) studied this question.

synapsesocial.com/papers/6a7ce316c7b2140ec7fec039 https://doi.org/10.1002/ajh.23165

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Reversal of antithrombotic agents

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Reversal of antithrombotic agents

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider